Literature DB >> 2338652

Comparison of the response to 5-carboxamidotryptamine and serotonin in isolated human, monkey and dog coronary arteries.

N Toda1, T Okamura.   

Abstract

In isolated dog coronary arteries, serotonin (5-HT) produced a contraction, whereas 5-carboxamidotryptamine (5-CT), a serotonergic 5-HT1-like receptor agonist, mainly relaxed the arteries, and the contraction, if any, was slight. Human and Japanese monkey coronary artery strips responded to these amines only with contractions, the magnitude being markedly greater than that of serotonin-induced contractions in the dog arteries. Removal of endothelium slightly potentiated the serotonin-induced contraction and abolished the relaxation by 5-CT or reversed it to a contraction in the dog arteries; however, contractions elicited by serotonin and 5-CT in the human and monkey arteries were not influenced. Treatment with 10(-7) M 5-CT suppressed the contraction by serotonin in the dog arteries but did not alter the response of the monkey arteries. Relaxation of the dog arteries with endothelium caused by 5-CT and contraction of the arteries denuded of endothelium were not inhibited by ketanserin but they were by methysergide. 5-CT-induced contractions of human and monkey coronary arteries were attenuated by ketanserin and methysergide, although the inhibition was less with the 5-HT2 antagonist. Ketanserin inhibited the contraction by serotonin to a greater extent than the 5-CT-induced contraction in the monkey arteries. It may be concluded that 5-CT stimulates 5-HT1-like and 5-HT2 receptor subtypes in smooth muscle of human and monkey epicardial coronary arteries but acts exclusively on 5-HT1-like receptors in endothelium and smooth muscle of dog coronary arteries. Serotonin contracts the primate arteries, possibly by predominant activation of 5-HT2 over 5-HT1-like receptors.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2338652

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  9 in total

Review 1.  Serotonin and blood pressure regulation.

Authors:  Stephanie W Watts; Shaun F Morrison; Robert Patrick Davis; Susan M Barman
Journal:  Pharmacol Rev       Date:  2012-03-08       Impact factor: 25.468

2.  5-Hydroxytryptamine-induced contractions of the human isolated saphenous vein: involvement of 5-HT2 and 5-HT1D-like receptors, and a comparison with grafted veins.

Authors:  W A Bax; D Van Heuven-Nolsen; E Bos; M L Simoons; P R Saxena
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1992-05       Impact factor: 3.000

3.  Comparison of contractile responses to 5-hydroxytryptamine and sumatriptan in human isolated coronary artery: synergy with the thromboxane A2-receptor agonist, U46619.

Authors:  T M Cocks; B K Kemp; D Pruneau; J A Angus
Journal:  Br J Pharmacol       Date:  1993-09       Impact factor: 8.739

4.  The relaxant 5-HT receptor in the dog coronary artery smooth muscle: pharmacological resemblance to the cloned 5-ht7 receptor subtype.

Authors:  J A Terrón
Journal:  Br J Pharmacol       Date:  1996-07       Impact factor: 8.739

5.  A comparison of the contractile effects of 5-hydroxytryptamine, sumatriptan and MK-462 on human coronary artery in vitro.

Authors:  A Ferro; J Longmore; R G Hill; M J Brown
Journal:  Br J Clin Pharmacol       Date:  1995-09       Impact factor: 4.335

6.  Functional 5-HT receptor subtypes in the isolated canine common carotid artery.

Authors:  S Vhora; S Chiba
Journal:  Heart Vessels       Date:  1994       Impact factor: 2.037

7.  5-Hydroxytryptamine (5-HT) contracts the guinea-pig isolated iliac artery via 5-HT1-like and 5-HT2 receptors.

Authors:  H Pertz
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1993-12       Impact factor: 3.000

8.  Subcutaneous delivery of sumatriptan in the treatment of migraine and primary headache.

Authors:  Johanna C Moore; James R Miner
Journal:  Patient Prefer Adherence       Date:  2012-01-04       Impact factor: 2.711

9.  Characterization of the 5-HT receptor subtypes involved in the motor behaviours produced by intrathecal administration of 5-HT agonists in rats.

Authors:  K C Fone; A J Robinson; C A Marsden
Journal:  Br J Pharmacol       Date:  1991-06       Impact factor: 9.473

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.